HIV / AIDS in the News

Another HIV Treatment Option – but with Less Weight Gain | Newswise - Newswise

 

Merck Shares Access Strategy for Investigational Monthly PrEP Alimatravir - Drug Topics

 

AIDS 2026: Engineering adaptive NK cells against HIV - BioWorld News

 

Have 7,000 Karnataka students tested positive for HIV? Here's the truth - WION

 

US admits 'unfortunate error' after mislabelling countries on map of Africa - BBC

 

Pricing pivotal as HIV drug advances offer ‘choice’ - SciDev.Net

 

A New Kind of HIV Pill Just Passed Its First Test in Humans - ScienceAlert

 

SNAP Payment Cycle Linked With Short-Term Changes in ART Adherence - Infectious Disease Special Edition

 

Trump to HIV and Cancer Patients: Get Back to Work - The American Prospect

 

PEPFAR cuts close key population services and accelerate decline in children's HIV treatment - Aidsmap

 

US government mislabels countries on map of Africa at global conference - Al Jazeera

 

HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts - The Guardian

 

Two more people cured of HIV after stem cell transplants, offering more clues to long-term remission - Aidsmap

 

Real-World Data Support BIC/FTC/TAF Switch in Adults With HIV - Infectious Disease Advisor

 

Long-Acting ART Achieves HIV Virologic Suppression in Patients With Viremia - Infectious Disease Advisor

 

Wealth inequality driving HIV and other pandemics, researchers say - euractiv.com

 

Missed Opportunities: The Importance of HIV Screening in Adolescent Populations - Cureus

 

Missed Opportunities: The Importance of HIV Screening in Adolescent Populations - Cureus

 

[AIDS 2026] Health Policy Watch: Adjusting to a post-PEPFAR world - European AIDS Treatment Group

 

[AIDS 2026] Health Policy Watch: Fiji has the world’s fastest growing HIV epidemic – and it is struggling - European AIDS Treatment Group

 

St. Jude enrolls patients in trial for monthly HIV prevention pill - FOX13 Memphis

 

Probiotic-derived bioactive metabolite reverses gut dysfunction and boosts HIV treatment response - medicalxpress.com

 

[AIDS 2026] aidsmap: Long-acting injectable treatment superior to daily pills for adolescents in African trial - European AIDS Treatment Group

 

[AIDS 2026] aidsmap: Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP) - European AIDS Treatment Group

 

Being HIV Positive in Pennsylvania Is No Longer a Crime - POZ

 

[AIDS 2026] aidsmap: Once-weekly islatravir/lenacapavir combination pill maintains HIV viral suppression - European AIDS Treatment Group

 

[AIDS 2026] aidsmap: Islatravir plus ulonivirine shows promise for weekly oral HIV treatment - European AIDS Treatment Group

 

[AIDS 2026] aidsmap: Dolutegravir knocks down HIV faster than bictegravir - European AIDS Treatment Group

 

Suspected Lamotrigine-Associated Haematological Adverse Reaction in the Context of Polypharmacy, Alcohol Use, HIV, and Recent Medication Changes - Cureus

 

Trump officials mislabel all African countries on map at global AIDS conference as U.S. cuts HIV aid - Advocate.com